Advertisement

Haemodynamic and Metabolic Effects of Nicergoline in Healthy and Arteritic Patients at Rest or During Exercise

  • F. Boismare
  • N. Moore

Abstract

Nicergoline is a hemisynthetic derivative of ergot alcaloids, which has been shown to have a predominant alpha-1 blocking activity with a slight activity on alpha-2 receptors [8, 15]. This alpha-blocking and, therefore, vasodilating effect has justified the study of the vascular effects of the drug in healthy subjects and in patients with peripheral arterial disease.

Keywords

Cardiac Output Peripheral Arterial Disease Arterial Disease Lactic Acidaemia Obstructive Arterial Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boismare F, Lefraneois J (1980) Haemodynamic effects of nicergoline in man at rest and during exercise. Clin Exp Pharmacol Physiol 7: 105–112PubMedCrossRefGoogle Scholar
  2. 2.
    Boismare F, Philippe JC, Leduc X (1974) Etude rhéographique de l’effet de la nicergoline sur la circulation des membres inférieurs chez le sujet sain et chez l’artéritique. Thérapie 29: 925–932PubMedGoogle Scholar
  3. 3.
    Boismare F, Lefraneois J, Leclerc JL, Moore N, Paux G (1979) Influence du décubitus sur l’hémodynamique du sujet sain, traité ou non par la nicergoline. J Pharmacol 10: 455–460Google Scholar
  4. 4.
    Boismare F, Leclerc JL, Lefraneois J, Moore N, Paux G, Schrub JC, Vuillermet P (1981) Effets hémodynamiques et métaboliques de l’épreuve d’effort chez l’artéritique diabétique traité ou non par la nicergoline. Sem Hôp Paris 57: 1455–1457PubMedGoogle Scholar
  5. 5.
    Branchereau A, Sicardi F (1977) Recherche d’un effet antiaggrégant plaquettaire en pathologie artérielle; essai d’un alpha-bloquant, la nicergoline. Méditerr Méd 135: 43–46Google Scholar
  6. 6.
    DerAgopian P, Rosa A, Gautier JC, Lhermitte F (1973) Thromboses expérimentales: effets d’un alpha-bloquant, la nicergoline. Nouv Press Med 2: 2521–2524Google Scholar
  7. 7.
    Denniston JC (1976) Measurement of cardiac output by electrical impedance at rest and during exercise. J Appl Physiol 40: 91–95PubMedGoogle Scholar
  8. 8.
    Huchet AM, Mouille P, Chelly J, Lucet B, Doursout MF, Lechat P, Schmitt H (1981) Effects of nicergoline on the cardiovascular system of dogs and rats. J Cardiovasc Pharmacol 3: 677–691PubMedCrossRefGoogle Scholar
  9. 9.
    Judy WV (1969) Comparative evaluation of the thoracic impedance and isotope dilution methods for measuring cardiac output. Aerospace Med 40: 532PubMedGoogle Scholar
  10. 10.
    Kubicek WG (1966) Development and evaluation of an impedance cardiac output system. Aerospace Med 37: 1208PubMedGoogle Scholar
  11. 11.
    Lagarde M, Guichardant M, Ghazi I, Dechavanne M (1980) Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospolipids. Prostaglandins 19: 551–557PubMedCrossRefGoogle Scholar
  12. 12.
    Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60: 481–497PubMedGoogle Scholar
  13. 13.
    Lemenn R, Migne J, Prost-Dvojakovic RJ (1977) Etude ultrastructurale de l’action d’un anti-aggrégant sur les plaquettes sanguines: application à la nicergoline. Thérapie 32: 205–214Google Scholar
  14. 14.
    Migne J, Saint-Maurice JP, Santonja R, Kunz S (1974) Activité anti-aggrégante plaquet- taire: effets d’un alpha-bloqueur, la nicergoline. Sem Hôp Paris 50: 649–655Google Scholar
  15. 15.
    Moore ND, Cazor JL, Leclerc JL, Saligaut C, Boismare F (1981) Some haemodynamie effects of nicergoline, a new alpha-blocking agent, in the closed-chest anaesthetized dog as compared with nitroprusside and nitroglycerin. Arzneimittelforsch/Drug Res 31: 10, 1693–1698Google Scholar
  16. 16.
    Praga C, PogUani E (1971) Effect of nicergoline (F 6714) on human platelet aggregation in vitro. Acta Med Scand [Suppl] 519: 263–266Google Scholar
  17. 17.
    Praga C, Tantalo Y, Marangoni R (1979) Nicergoline and platelet aggregation: a review of experimental and clinical studies. Arzneimittelforsch/Drug Res 29: 1270–1277Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • F. Boismare
  • N. Moore
    • 1
  1. 1.Laboratoire de PharmacologieUER de Médecine-Pharmacie de RouenSt. Etienne-du-RouvrayFrance

Personalised recommendations